Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...
Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy.
BJP MLA Vijender Gupta on Thursday urged lieutenant governor V K Saxena to implement the Pradhan Mantri Ayushman Bharat ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The advertising-technology company reports quarterly earnings above estimates but sales that are lower than consensus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results